AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2019
Nov 27, 2019
29821_dirs_2019-11-27_5d06f1c3-b1c1-4e1c-aec6-37f1fb4ca54f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2019-11-26
Reporting Person: Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-26 | Common Stock | M | 9866.0000 | $7.7400 | Acquired | 98843.9900 | Direct |
| 2019-11-26 | Common Stock | S | 22487.0000 | $42.7027 | Disposed | 76356.9900 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-11-26 | Stock Option (Right to Buy) | $7.7400 | M | 9866.0000 | Disposed | 2020-02-26 | Common Stock (9866.0000) | Direct |
Footnotes
F1: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.66 to $42.73, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 26, 2011, the first anniversary of the date of grant.